Catalyst Wire Dossier Catalyst Wire Dossier

Niagen Plus

nicotinamide riboside · ChromaDex, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Niagen Plus, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus [Phase 1]

See pricing